A case of immune-related adverse events, thyroid dysfunction, myocarditis with myositis, and myasthenia gravis overlap syndrome following serplulimab administration for lung adenocarcinoma | Synapse
A case of immune-related adverse events, thyroid dysfunction, myocarditis with myositis, and myasthenia gravis overlap syndrome following serplulimab administration for lung adenocarcinoma
The research aims to understand the complex immune-related adverse events following serplulimab treatment for lung adenocarcinoma.
Case study analysis of immune-related adverse events
Collaboration among multiple medical specialties
Monitoring of thyroid dysfunction, myocarditis, and myasthenia gravis
Identification of multiple organ adverse effects linked to serplulimab
Need for enhanced patient monitoring during treatment
Emphasis on biomarker research to improve patient safety and treatment efficacy
Abstract
The serplulimab-induced multiorgan irAEs necessitates enhanced monitoring, biomarker research, and multidisciplinary collaboration to optimize safety and antitumor efficacy.